Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe version history shows four new Results Submission Events added and three removed, updating the record with recent results submission activity. This reflects ongoing maintenance of the study record.SummaryDifference0.1%

- Check14 days agoChange DetectedA new Revision: v3.4.2 was added to the history. The previous government funding operating status notice and Revision: v3.4.1 were removed.SummaryDifference0.7%

- Check21 days agoChange DetectedA new site notice about government funding lapse and operation status is added. The history shows a new revision labeled v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history page now includes a 'Show glossary' option and color-coding for changes (green for additions, red for deletions), and the revision tag has been updated from v3.3.4 to v3.4.0.SummaryDifference0.9%

- Check35 days agoChange DetectedThe history shows a new revision: v3.3.4, replacing the previous v3.3.3. This is a minor update with no evident changes to study data, layout, or navigation.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 to the history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.